Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Highlights

Highlights In This Issue October 2019 Volume 76, Number 10 JAMA Psychiatry Pages 997-1108 Research Opinion Editor's Note Estradiol for Schizophrenia Among Women of Childbearing Age 1009 1017 Challenges When Conducting Estradiol is reported to have antipsychotic properties, but this has not been independently Complex Clinical Research replicated. Weiser and colleagues conducted a single-site 8-week randomized placebo- D Ongür controlled trial of 200 μg of estradiol in a patch in 100 women of childbearing age and found that the estradiol patch led to significantly greater improvement in the primary outcome LETTERS than placebo, with the strongest effect in older women. These results replicate the finding Research Letter that estradiol is antipsychotic in women of childbearing age and they have implications for 1094 Association of Quetiapine Overuse new therapeutic approaches. Letters With Prescribing by Physician Editor’s Note 1017 Peers of Targeted Recipients: A Secondary Continuing Medical Education jamanetwork.com/learning Analysis of a Randomized Clinical Trial A Sacarny and Coauthors Schizophrenia Risk in Indian Genome-wide Association Study 1026 Comment & Response Most genome-wide association studies in schizophrenia have been conducted in Euro- 1095 Lead Exposure as a Confounding Factor in the Association of Air Pollution pean populations to date. Periyasamy and colleagues present http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Psychiatry American Medical Association

Highlights

JAMA Psychiatry , Volume 76 (10) – Oct 1, 2019

Highlights

Abstract

In This Issue October 2019 Volume 76, Number 10 JAMA Psychiatry Pages 997-1108 Research Opinion Editor's Note Estradiol for Schizophrenia Among Women of Childbearing Age 1009 1017 Challenges When Conducting Estradiol is reported to have antipsychotic properties, but this has not been independently Complex Clinical Research replicated. Weiser and colleagues conducted a single-site 8-week randomized placebo- D Ongür controlled trial of 200 μg of estradiol in a patch in 100 women of...
Loading next page...
 
/lp/american-medical-association/highlights-zrUu2KMcrE
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-622X
eISSN
2168-6238
DOI
10.1001/jamapsychiatry.2018.3005
Publisher site
See Article on Publisher Site

Abstract

In This Issue October 2019 Volume 76, Number 10 JAMA Psychiatry Pages 997-1108 Research Opinion Editor's Note Estradiol for Schizophrenia Among Women of Childbearing Age 1009 1017 Challenges When Conducting Estradiol is reported to have antipsychotic properties, but this has not been independently Complex Clinical Research replicated. Weiser and colleagues conducted a single-site 8-week randomized placebo- D Ongür controlled trial of 200 μg of estradiol in a patch in 100 women of childbearing age and found that the estradiol patch led to significantly greater improvement in the primary outcome LETTERS than placebo, with the strongest effect in older women. These results replicate the finding Research Letter that estradiol is antipsychotic in women of childbearing age and they have implications for 1094 Association of Quetiapine Overuse new therapeutic approaches. Letters With Prescribing by Physician Editor’s Note 1017 Peers of Targeted Recipients: A Secondary Continuing Medical Education jamanetwork.com/learning Analysis of a Randomized Clinical Trial A Sacarny and Coauthors Schizophrenia Risk in Indian Genome-wide Association Study 1026 Comment & Response Most genome-wide association studies in schizophrenia have been conducted in Euro- 1095 Lead Exposure as a Confounding Factor in the Association of Air Pollution pean populations to date. Periyasamy and colleagues present

Journal

JAMA PsychiatryAmerican Medical Association

Published: Oct 1, 2019

There are no references for this article.